Study identifier:D9603R00007
ClinicalTrials.gov identifier:NCT05898412
EudraCT identifier:N/A
CTIS identifier:N/A
Retrospective real world evidence study to describe characteristics and outcomes in Dutch patients admitted to the hospital with a factor Xa inhibitor-associated bleeding treated with andexanet alfa
Hemorrhage
N/A
No
Andexanet alfa
All
100
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
LOGEX Healthcare Analytics Amsterdam The Netherlands
No locations available
Arms | Assigned Interventions |
---|---|
Andexanet alfa Hospitalized patients treated with andexanet alfa | - |